These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32414200)

  • 1. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
    Fukuwatari T
    Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro.
    Sekine A; Okamoto M; Kanatani Y; Sano M; Shibata K; Fukuwatari T
    Springerplus; 2015; 4():48. PubMed ID: 25674503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain.
    Pérez-de la Cruz V; Amori L; Sathyasaikumar KV; Wang XD; Notarangelo FM; Wu HQ; Schwarcz R
    J Neurochem; 2012 Mar; 120(6):1026-35. PubMed ID: 22224417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute liver failure increases kynurenic acid production in rat brain via changes in tryptophan metabolism in the periphery.
    Sekine A; Fukuwatari T
    Neurosci Lett; 2019 May; 701():14-19. PubMed ID: 30738081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of quinolinic and kynurenic acids.
    Stone TW
    Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
    Wonodi I; Schwarcz R
    Schizophr Bull; 2010 Mar; 36(2):211-8. PubMed ID: 20147364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.
    Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.
    Ramos-Chávez LA; Lugo Huitrón R; González Esquivel D; Pineda B; Ríos C; Silva-Adaya D; Sánchez-Chapul L; Roldán-Roldán G; Pérez de la Cruz V
    Oxid Med Cell Longev; 2018; 2018():5272741. PubMed ID: 29977455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does kynurenic acid act on nicotinic receptors? An assessment of the evidence.
    Stone TW
    J Neurochem; 2020 Mar; 152(6):627-649. PubMed ID: 31693759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
    Erhardt S; Olsson SK; Engberg G
    CNS Drugs; 2009; 23(2):91-101. PubMed ID: 19173370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic Stroke and Kynurenines: Medicinal Chemistry Aspects.
    Hertelendy P; Toldi J; Fülöp F; Vécsei L
    Curr Med Chem; 2018; 25(42):5945-5957. PubMed ID: 29532751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
    Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
    Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
    Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
    J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kynurenine pathway in schizophrenia and bipolar disorder.
    Erhardt S; Schwieler L; Imbeault S; Engberg G
    Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.